LABGENIUS
LabGenius is a biopharmaceutical company developing protein therapeutics using a machine learning-driven evolution engine. Its protein engineering platform integrates several bleeding-edge technologies from the fields of machine learning, synthetic biology, and robotics.
LABGENIUS
Industry:
Artificial Intelligence Biotechnology Machine Learning Robotics Therapeutics
Founded:
2012-09-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.labgeni.us
Total Employee:
51+
Status:
Active
Total Funding:
28.66 M USD
Technology used in webpage:
Viewport Meta SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Global Site Tag
Similar Organizations
CellVision
CellVision is a computational system that discovers drug action in cells using image analysis and machine learning algorithms.
Menten AI
Menten AI develops peptide and protein therapeutics using machine learning and quantum computing.
Current Advisors List
Board_member
Board_member
2017-09-01
Board_member
2020-02-01
Board_member
Board_member
Board_member
2019-07-01
Current Employees Featured
James Field CEO & Founder @ LabGenius
CEO & Founder
2012-08-01
Harry Rickerby Platform Architect @ LabGenius
Platform Architect
2017-01-01
Dr Gino Van Heeke Chief Scientific Officer @ LabGenius
Chief Scientific Officer
2021-11-01
Ben Mackrow Lead Synthetic Biologist @ LabGenius
Lead Synthetic Biologist
2015-10-01
Dr. Didier Landais Chief Operating Officer @ LabGenius
Chief Operating Officer
2021-09-01
Staffan Piledahl Software Engineer @ LabGenius
Software Engineer
2018-03-01
Founder
Investors List
Inovia Capital
Inovia Capital investment in Series A - LabGenius
Lux Capital
Lux Capital investment in Series A - LabGenius
Obvious Ventures
Obvious Ventures investment in Series A - LabGenius
Atomico
Atomico investment in Series A - LabGenius
Kindred Capital
Kindred Capital investment in Series A - LabGenius
Gigafund
Gigafund investment in Series A - LabGenius
Air Street Capital
Air Street Capital investment in Series A - LabGenius
Felicis Ventures
Felicis Ventures investment in Series A - LabGenius
Chris Gibson
Chris Gibson investment in Series A - LabGenius
Patrick Pichette
Patrick Pichette investment in Series A - LabGenius
Key Employee Changes
| Date | New article |
|---|---|
| 2021-11-29 | LabGenius Appoints Dr. Gino Van Heeke as Chief Scientific Officer |
| 2021-09-22 | LabGenius Appoints Dr. Didier Landais as Chief Operating Officer |
Official Site Inspections
http://www.labgeni.us Semrush global rank: 2.44 M Semrush visits lastest month: 7.34 K
- Host name: 23.185.0.1
- IP address: 23.185.0.1
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "LabGenius"
LabGenius - Crunchbase Company Profile & Funding
LabGenius may be growing as it operates within the European biotech startup sector, which continues to attract significant investment. The article indicates that despite broader economic …See details»
LabGenius Company Information - Funding, Investors, and More
LabGenius has significant potential due to its innovative approach combining biopharmaceutical development with advanced machine learning. Located in London and targeting a B2B market, …See details»
LabGenius - Overview, News & Similar companies | ZoomInfo.com
Apr 4, 2023 View LabGenius (www.labgeni.us) location in Greater London, United Kingdom , revenue, industry and description. Find related and similar companies as well as employees …See details»
LabGenius - Company Profile - Tracxn
LabGenius - Manufacturer of synthetic DNA libraries. Raised a total funding of $73.2M over 5 rounds from 23 investors.See details»
Departments - LabGenius
Headquartered in London, LabGenius is a leading machine learning-driven protein engineering company. The company’s core technology platform, EVA™, enables the rapid discovery of …See details»
Press release | LabGenius Appoints Dr. Hannah Seitz as Chief …
Jan 10, 2025 LabGenius operates under a hybrid business model that involves partnering with large biotech and pharmaceutical companies in parallel with pursuing a wholly-owned …See details»
LabGenius - Craft
LabGenius is a company that provides machine learning (ML) driven antibody discovery solutions. It develops a technology platform for the discovery and optimization of novel therapeutic …See details»
Press release | LabGenius raises £35 million led by M Ventures to ...
May 21, 2024 Additional new investors Octopus Ventures and LG Corp joined the Series B round together with existing investors including Atomico, Kindred Capital, Lux Capital and …See details»
LabGenius Company Overview, Contact Details & Competitors
May 21, 2024 Learn more about LabGenius's company details, contact information, competitors, and more. Find accurate contact data easily with LeadIQ. Book a demo today.See details»
LabGenius Therapeutics | ML-driven Antibody Discovery
Combining human and machine intelligence to discover the next generation of therapeutic antibodies.See details»
LabGenius - Medium
Dec 22, 2023 James Field CEO & Founder at LabGenius (@labgeni_us), Forbes 30 Under 30, BBSRC Innovator of the Year, Synbio LEAP fellow, DadSee details»
LABGENIUS LIMITED - F6S
LABGENIUS LIMITED - Since the advent of life 3.6 billion years ago, the survival all species has depended on rapid innovation at the genetic level. At LabGenius, we harness Nature’s evolved …See details»
People - LabGenius
Headquartered in London, LabGenius is a leading machine learning-driven protein engineering company. The company’s core technology platform, EVA™, enables the rapid discovery of …See details»
Working At LabGenius: Company Overview and Culture - Zippia
Mar 14, 2024 Find out what it's like to work at LabGenius. See what kind of people work at LabGenius, career paths working at LabGenius, company culture, salaries, employee political …See details»
Get to know LabGenius' CTO, Ex-Rahko co-founder & CEO and …
Mar 10, 2023 About LabGenius Headquartered in London, LabGenius is a leading machine learning-driven protein engineering company. The company’s core technology platform, …See details»
Antibody Engineering - LabGenius
The Protein Expression & Purification Team produces and characterises potential drugs and target molecules. Using our state-of-the-art high-throughput protein engineering suite, we are …See details»
LabGen AI
LabGeni AI AI-driven Laboratory Information System Elevate lab efficiency with AI-driven LIMS. Automate tasks, ensure data quality, and streamline operations with real-time insights and …See details»
LabGenius’ £35 million Series B - Medium
May 21, 2024 Today, we announce LabGenius’ £35 million Series B (ref). With this capital, we’ll be doubling down on our antibody discovery platform and therapeutic pipeline, but the benefits …See details»
LabGenius announces research collaboration with Ablynx, a Sanofi ...
LONDON, United Kingdom – 15/07/21 - LabGenius, a pioneer in the use of machine learning (ML) for protein engineering, today announced the signing of a multi-year research collaboration …See details»
Press release | LabGenius’ Research Collaboration with Sanofi …
Sep 18, 2023 For more information, please visit www.labgeni.us, or connect on Twitter, LinkedIn and Medium. For more information, please contact: Media enquiries: Communications Lead …See details»